Cara Therapeutics to Participate in Webcast on Pain

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cara Therapeutics to Participate in Webcast on Pain Targeting Mechanisms
  • Webcast to be held Thursday, October 6, 2016 at 11:00 a.m. ET

STAMFORD, Conn., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that Dr. Derek Chalmers, President and Chief Executive Officer, will participate in a webcast featuring innovations in pain management therapies. The webcast is part of a series from Biopharma Dealmakers , a quarterly supplement in Nature Biotechnology and Nature Reviews Drug Discovery .

Four companies that are working to address unmet needs in pain management will present their developments, which include analgesics with novel mechanisms of action, medical devices, and opioids with reduced potential for abuse and physical dependence. The webcast will also include a roundtable discussion and a question and answer session with Dr. Chalmers and the other speakers.

Details for the webcast are as follows:

Date :  Thursday, October 6, 2016 Time :  11:00 a.m. ET Moderator :  Raveena Bhambra, Editor of BioPharma Dealmakers Participants :

  • Dr. Derek Chalmers, President and CEO of Cara Therapeutics
  • Dr. Jeffrey Herz, President and CEO of Algomedix, Inc.
  • Dr. Jessica Preciado, Director of Product Development and Principal Scientist of Myoscience
  • Dr. Steve Doberstein, Senior Vice President and Chief Scientific Officer of Nektar Therapeutics

For more information, and to register for this free webcast, visit: http://www.workcast.com/register?cpak=5922214...erapeutics .

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body's peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

INVESTOR CONTACT: Jesse Baumgartner Stern Investor Relations, Inc. 212-362-1200 Jesse@sternir.com MEDIA CONTACT: Annie Starr 6 Degrees 973-415-8838 astarr@6degreespr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 34

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 41

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 40

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 32

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 39

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 32

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 24

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading

Top 5 Most Recently Viewed Articles

ionstream.ai Launches New GPU Platform for AI Efficiency

Updated Category News Views 267

ionstream.ai Unveils Cloud GPU Platform Featuring NVIDIA L40S Cost-Effective GPU Infrastructure for AI Inference and Fine-Tuning ionstream.ai, recognized as a leader in enterprise GPU infrastructure, has launched the NVIDIA L40S GPUs on its innovative GPU as a Service (GaaS) platform. This expansion is set to transform the way organizations approach AI inference and model...

Continue Reading
SurgePays Secures $7M Financing for National Expansion Plans

Updated Category News Views 156

SurgePays Secures $7 Million Debt Financing In an exciting development, SurgePays, Inc. (NASDAQ: SURG), a company recognized for its innovative wireless and point-of-sale technology, has successfully entered into a debt financing agreement amounting to $7 million. This agreement involves a senior secured convertible note with an esteemed institutional shareholder. The...

Continue Reading
Fission Uranium Corp. Proposes Changes to Interim Order

Updated Category News Views 78

Fission Uranium Corp. Announces Proposed Changes to Interim Order Fission Uranium Corp. has revealed its intention to seek changes to the interim order in relation to the upcoming meeting of its securityholders. This amendment is crucial for the special arrangements tied to the proposed plan of arrangement with Paladin Energy Limited. Details of the Proposed Changes The...

Continue Reading
Iceland Offers Purchase of €203.7 Million in Notes, Results Inside

Updated Category News Views 125

Overview of Iceland's Recent Offer The Republic of Iceland, referred to as the Offeror, has recently made waves in the financial markets by announcing the results of its invitation to holders of its significant €500,000,000 0.625% Notes due June 3, 2026. This announcement effectively invites stakeholders to tender their notes for a cash purchase, stirring interest among...

Continue Reading
Join the Fight: Investors of The Bancorp, Inc. Take Action

Updated Category News Views 288

The Bancorp, Inc. Class Action Lawsuit Overview In a notable turn of events, investors who have faced substantial losses from their investments in The Bancorp, Inc. (NASDAQ: TBBK) now have the opportunity to lead a class action lawsuit. The announcement has spurred many to seek justice for the financial setbacks they have experienced during the designated Class Period,...

Continue Reading